On June 30, 2020 Goodwin’s Life Sciences group presented the third of four weekly webinars aiming to provide a multidisciplinary outlook on top-of-mind issues facing European life sciences companies in the era of COVID-19.
At this event, Goodwin Life Sciences partner Robert Puopolo moderated a conversation with Goodwin’s Life Sciences IP partner Duncan Greenhalgh and Licensing & Collaboration partner Malcolm Bates along with Achilles Therapeutics Limited's Chief Business Officer, Beverly Carr, and VP of Intellectual Property, Liz Elmhirst, as they discuss market developments, challenges and opportunities in the currently unfolding COVID-19 pandemic from IP, licensing and collaborations perspectives.
The Recording:
Visit Goodwin’s Coronavirus Knowledge Center, where firm lawyers from across the globe are issuing new guidance and insights to help clients fully understand and assess the ramifications of COVID-19 and navigate the potential effects of the outbreak on their businesses.